BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2961630)

  • 1. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment.
    Fiedler VC; Buys CM
    Dermatologica; 1987; 175 Suppl 2():29-35. PubMed ID: 2961630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration.
    Khoury EL; Price VH; Abdel-Salam MM; Stern M; Greenspan JS
    J Invest Dermatol; 1992 Jul; 99(1):40-7. PubMed ID: 1607678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation.
    Fiedler-Weiss VC; Buys CM
    Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of minoxidil-induced hair growth in alopecia areata.
    Fiedler-Weiss VC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):653-6. PubMed ID: 3558910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata treated with topical minoxidil.
    Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA
    Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minoxidil.
    Fiedler-Weiss VC
    Dermatol Clin; 1987 Jul; 5(3):627-35. PubMed ID: 3301118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
    Fiedler-Weiss VC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):745-8. PubMed ID: 3549811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oral minoxidil in the treatment of alopecia areata.
    Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
    Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical minoxidil in the treatment of alopecia areata.
    Fenton DA; Wilkinson JD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1015-7. PubMed ID: 6412929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
    El-Ashmawy AA; El-Maadawy IH; El-Maghraby GM
    J Dermatolog Treat; 2018 Feb; 29(1):55-64. PubMed ID: 28521549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica.
    Clissold SP; Heel RC
    Drugs; 1987 Feb; 33(2):107-22. PubMed ID: 3552591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive alopecia areata. Results of treatment with 3% topical minoxidil.
    Ranchoff RE; Bergfeld WF; Steck WD; Subichin SJ
    Cleve Clin J Med; 1989; 56(2):149-54. PubMed ID: 2659203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical minoxidil in extensive alopecia areata, including 3-year follow-up.
    Price VH
    Dermatologica; 1987; 175 Suppl 2():36-41. PubMed ID: 3691913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
    Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
    Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.